Malaria Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Malaria Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Therapeutic Area

Report Description

1
1

The impact of malaria is serious and getting worse throughout the world. Malaria remains a significant cause of death and illness among adults and children. Controlling of malaria needs an incorporated approach, comprising prompt treatment and prevention with effective antimalarial agents. Malaria is typically prevalent in hot climate. Anopheles mosquito, that transfers malaria parasite from one person to another, thrives in warm, moist climate where ponds of water offer it the perfect breeding platforms. Malaria is highly prevalent in conditions where health care systems are inadequate and awareness is low. Malaria is curable disease if effective treatment is initiated early. Delay in action may lead to severe implications, including death. Effective and prompt treatment is also important for controlling the spread of malaria. The cost of malaria is enormous for human and social being as the disease typically attacks not once but repeatedly into affected victims. The World Bank and the World Health Organization (WHO) rank malaria as the single largest factor of disease in Africa, causing disability and premature mortality.

Increase in government expenditure for prevention of malaria is a key driving factor for the malaria treatment market. According to the WHO, the estimated total funding for control and elimination of malaria was US$ 2.9 Bn in 2015. Moreover, in 2015, around 212 million cases of malaria were reported and 429,000 deaths were caused by malaria globally. Thus, high prevalence and disease burden of malaria are expected to drive the malaria treatment market during the forecast period.

The global malaria treatment market can be segmented depending on treatment type, route of administration, end-user, and geography. Based on treatment type, the global malaria treatment market can be categorized into vaccines, anti-malarial agents, diagnostic tests, and indicators. On the basis of route of administration, the malaria treatment market can be classified into oral, intravenous, and parenteral. Based on end-user, the global malaria treatment market can be divided into hospitals, specialty clinics, and others.

In terms of geography, the global malaria treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Further, the malaria treatment market in North America can be bifurcated into the U.S. and Canada. The malaria treatment market in Europe can be divided into the U.K., Germany, France, Italy, Spain, and Rest of Europe. The malaria treatment market in Asia Pacific can be further classified into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific. Mexico, Brazil, and Rest of Latin America are the sub-segments of the malaria treatment market in Latin America, while the market in Middle East & Africa comprises Saudi Arabia, South Africa, Israel, and Rest of Middle East & Africa. Prevalence of malaria is higher in Asia Pacific and Middle East & Africa region as compared to that in North America and Europe. According to statistics published by the WHO in 2016, the highest number cases of malaria were detected in Asia Pacific and Middle East & Africa. It is estimated that 53% of the population in Middle East & Africa is at risk of malaria. According to the WHO, 58% of the cases of malaria caused by P. vivax occurs in Asia Pacific, followed by Middle East & Africa. Moreover, around 76% of the registered cases of malaria in 2015 were from just 13 countries. India, Ethiopia, Pakistan, and Indonesia accounted for high prevalence of malaria due to P. vivax.

Some of the key players operating in malaria treatment market are Novartis AG, Pfizer, Inc., Amyris,  GlaxoSmithKline, Concordia International Corp., Lannett Company, Inc.,  Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Inc., Fresenius Kabi, LLC, Roxane Laboratories, Inc., Baxter International Inc., and Sanofi.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074